On Dec. 17, SleepRes, Inc. announced it has received FDA 510(k) clearance for its Kricket PAP device, powered by Kairos Positive Airway Pressure (KPAP) for the treatment of obstructive sleep apnea in patients over 66 pounds.
About Kricket PAP
The Kricket PAP device uses KPAP technology to dynamically adapt pressure delivery throughout the breathing cycle, rather than maintaining a constant, fixed pressure like traditional CPAP devices. KPAP is a new pressure algorithm designed to follow the natural rhythm of breathing and apply pressure only when needed.
With substantially reduced airway pressure during both inspiration and much of expiration, KPAP returns pressure to the optimal treatment level toward the end of expiration. Derived from the Greek word Kairos, meaning “at the right time,” the algorithm provides full therapeutic pressure at end-expiration, when the upper airway is more susceptible to narrowing or collapse.
KPAP technology was designed to address discomfort associated with CPAP therapy by synchronizing treatment with a patient’s natural respiration and airway dynamics. By reducing unnecessary pressure, the approach aims to minimize discomfort, alleviate common side effects, and improve tolerance during sleep.
The Kricket PAP device includes the KPAP algorithm, as well as traditional CPAP and automatic PAP therapy modes.
The system is intended for use in home, hospital or institutional, and sleep center settings. In a press release, SleepRes said it plans to launch Kricket in the first half of 2026.
About obstructive sleep apnea
Obstructive sleep apnea is a serious sleep disorder where the airway becomes repeatedly blocked during sleep, causing pauses in breathing. This condition, often marked by loud snoring and choking noises, can lead to oxygen deprivation, disrupting sleep and contributing to various health issues such as high blood pressure, heart disease, stroke and diabetes.
Read more industry news from the AASM.
